Trade VBI Vaccines Inc. - VBIV CFD

Add to favourite

0.53

1.92%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.05

Long position overnight fee

-0.023485%

Short position overnight fee

0.001262%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.52
Open	0.52
1-Year Change	-60%
Day's Range	0.52 - 0.53

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Jul 29, 2024	0.53	0.00	0.00%	0.53	0.53	0.52
Jul 26, 2024	0.52	0.01	1.96%	0.51	0.53	0.50
Jul 25, 2024	0.52	0.01	1.96%	0.51	0.52	0.48
Jul 24, 2024	0.53	-0.03	-5.36%	0.56	0.56	0.51
Jul 23, 2024	0.56	-0.01	-1.75%	0.57	0.58	0.54
Jul 22, 2024	0.59	0.03	5.36%	0.56	0.61	0.55
Jul 19, 2024	0.57	-0.07	-10.94%	0.64	0.65	0.57
Jul 18, 2024	0.63	-0.07	-10.00%	0.70	0.72	0.59
Jul 17, 2024	0.70	-0.02	-2.78%	0.72	0.72	0.69
Jul 16, 2024	0.70	-0.04	-5.41%	0.74	0.75	0.70
Jul 15, 2024	0.73	-0.03	-3.95%	0.76	0.76	0.73
Jul 12, 2024	0.76	0.02	2.70%	0.74	0.77	0.72
Jul 11, 2024	0.74	0.01	1.37%	0.73	0.75	0.70
Jul 10, 2024	0.73	0.01	1.39%	0.72	0.73	0.70
Jul 9, 2024	0.72	-0.01	-1.37%	0.73	0.73	0.70
Jul 8, 2024	0.72	0.00	0.00%	0.72	0.74	0.72
Jul 5, 2024	0.70	-0.01	-1.41%	0.71	0.71	0.68
Jul 3, 2024	0.70	-0.02	-2.78%	0.72	0.75	0.69
Jul 2, 2024	0.69	0.04	6.15%	0.65	0.75	0.65
Jul 1, 2024	0.66	0.02	3.13%	0.64	0.67	0.64

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

VBI Vaccines Inc. Company profile

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company''s enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition For Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

Industry:

Biotechnology & Medical Research (NEC)

160 Second Street
Cambridge
CAMBRIDGE
MASSACHUSETTS 02142
US